UK price cuts feature in finalised price scheme
This article was originally published in Scrip
Executive Summary
The UK pharmaceutical industry has reached agreement with the government on a new pharmaceutical pricing scheme (PPRS) with both sides of the negotiations expressing satisfaction with the outcome. Price cuts are not to be as deep or rapid as first expected and pharmaceutical companies launching innovative medicines will have greater flexibility where pricing is concerned.